Literature DB >> 32720697

Effectiveness of Combined Anti-programmed Death-ligand 1 Therapy and Radiotherapy for Metastatic Merkel Cell Carcinoma: Two Case Reports.

Kanako Tsunoda1, Masazumi Onishi, Shinpei Miura, Hiroo Amano.   

Abstract

is missing (Short communication).

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32720697      PMCID： PMC9207656          DOI： 10.2340/00015555-3593

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


  13 in total

1.  Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunity.

Authors:  Shane E Cotter; Gavin P Dunn; Kristina M Collins; Debjani Sahni; Katherine A Zukotynski; Jorgen L Hansen; Desmond A O'Farrell; Andrea K Ng; Phillip M Devlin; Linda C Wang
Journal:  Arch Dermatol       Date:  2011-07

2.  Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8(+) T cells.

Authors:  Joanne Y H Lim; Scott A Gerber; Shawn P Murphy; Edith M Lord
Journal:  Cancer Immunol Immunother       Date:  2013-12-20       Impact factor: 6.968

Review 3.  Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.

Authors:  Dirk Schadendorf; Céleste Lebbé; Axel Zur Hausen; Marie-Françoise Avril; Subramanian Hariharan; Murtuza Bharmal; Jürgen C Becker
Journal:  Eur J Cancer       Date:  2016-12-14       Impact factor: 9.162

4.  Immunologic correlates of the abscopal effect in a patient with melanoma.

Authors:  Michael A Postow; Margaret K Callahan; Christopher A Barker; Yoshiya Yamada; Jianda Yuan; Shigehisa Kitano; Zhenyu Mu; Teresa Rasalan; Matthew Adamow; Erika Ritter; Christine Sedrak; Achim A Jungbluth; Ramon Chua; Arvin S Yang; Ruth-Ann Roman; Samuel Rosner; Brenna Benson; James P Allison; Alexander M Lesokhin; Sacha Gnjatic; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

5.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Authors:  Eric A Reits; James W Hodge; Carla A Herberts; Tom A Groothuis; Mala Chakraborty; Elizabeth K Wansley; Kevin Camphausen; Rosalie M Luiten; Arnold H de Ru; Joost Neijssen; Alexander Griekspoor; Elly Mesman; Frank A Verreck; Hergen Spits; Jeffrey Schlom; Peter van Veelen; Jacques J Neefjes
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

6.  Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma.

Authors:  Jayasri G Iyer; Astrid Blom; Ryan Doumani; Christopher Lewis; Erica S Tarabadkar; Austin Anderson; Christine Ma; Amy Bestick; Upendra Parvathaneni; Shailender Bhatia; Paul Nghiem
Journal:  Cancer Med       Date:  2016-07-19       Impact factor: 4.452

7.  In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series.

Authors:  Melody J Xu; Susan Wu; Adil I Daud; Siegrid S Yu; Sue S Yom
Journal:  J Immunother Cancer       Date:  2018-05-30       Impact factor: 13.751

Review 8.  Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma.

Authors:  Paul Nghiem; Howard L Kaufman; Murtuza Bharmal; Lisa Mahnke; Hemant Phatak; Jürgen C Becker
Journal:  Future Oncol       Date:  2017-03-28       Impact factor: 3.404

9.  Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab.

Authors:  Brooke C Bloom; Alexander Augustyn; Todd A Pezzi; Hari Menon; Lauren L Mayo; Shalin J Shah; David L Schwartz; Steven J Chmura; Faye M Johnson; James W Welsh; Stephen G Chun
Journal:  Front Oncol       Date:  2019-04-05       Impact factor: 6.244

10.  Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.

Authors:  Maike Trommer; Sin Yuin Yeo; Thorsten Persigehl; Anne Bunck; Holger Grüll; Max Schlaak; Sebastian Theurich; Michael von Bergwelt-Baildon; Janis Morgenthaler; Jan M Herter; Eren Celik; Simone Marnitz; Christian Baues
Journal:  Front Pharmacol       Date:  2019-05-14       Impact factor: 5.810
View more
  1 in total

1.  Lack of efficacy of radiation therapy plus PD-L1 blockade for Merkel cell carcinoma arising in a patient with chronic active Epstein-Barr virus infection.

Authors:  Ayaka Okazaki; Kozo Nakai; Nao Kusutani; Riei Kamo; Yoshie Fukunaga; Kotaro Nagase; Paul Nghiem; Daisuke Tsuruta
Journal:  Dermatol Ther       Date:  2021-01-05       Impact factor: 3.858
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.